Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.
Grønberg BH, Halvorsen TO, Fløtten Ø, Brustugun OT, Brunsvig PF, Aasebø U, Bremnes RM, Tollåli T, Hornslien K, Aksnessæther BY, Liaaen ED, Sundstrøm S; Norwegian Lung Cancer Study Group. Grønberg BH, et al. Among authors: aksnessaether by. Acta Oncol. 2016 May;55(5):591-7. doi: 10.3109/0284186X.2015.1092584. Epub 2015 Oct 23. Acta Oncol. 2016. PMID: 26494411 Clinical Trial.
Radiotherapy for prostate cancer - Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial.
Tøndel H, Lund JÅ, Lydersen S, Wanderås AD, Aksnessæther B, Jensen CA, Kaasa S, Solberg A. Tøndel H, et al. Radiother Oncol. 2018 Feb;126(2):229-235. doi: 10.1016/j.radonc.2017.10.029. Epub 2018 Feb 3. Radiother Oncol. 2018. PMID: 29398152 Clinical Trial.
Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial.
Aksnessæther BY, Myklebust TÅ, Solberg A, Klepp OH, Skovlund E, Hoff SR, Fosså SD, Widmark A, Lund JÅ. Aksnessæther BY, et al. Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):706-714. doi: 10.1016/j.ijrobp.2019.11.027. Epub 2019 Nov 28. Int J Radiat Oncol Biol Phys. 2020. PMID: 31786279 Clinical Trial.
In Reply to Sari et al.
Aksnessæther BY, Myklebust TÅ, Solberg A, Klepp OH, Skovlund E, Hoff SR, Fosså SD, Widmark A, Lund JÅ. Aksnessæther BY, et al. Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):388-389. doi: 10.1016/j.ijrobp.2020.02.027. Epub 2020 Feb 26. Int J Radiat Oncol Biol Phys. 2020. PMID: 32112877 No abstract available.
Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI.
Selnæs KM, Krüger-Stokke B, Elschot M, Johansen H, Steen PA, Langørgen S, Aksnessæther BY, Indrebø G, Sjøbakk TAE, Tessem MB, Moestue SA, Knobel H, Tandstad T, Bertilsson H, Solberg A, Bathen TF. Selnæs KM, et al. Among authors: aksnessaether by. Front Oncol. 2020 Dec 23;10:582092. doi: 10.3389/fonc.2020.582092. eCollection 2020. Front Oncol. 2020. PMID: 33425735 Free PMC article.
Added Value of [18F]PSMA-1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management.
Abrahamsen BS, Tandstad T, Aksnessæther BY, Bogsrud TV, Castillejo M, Hernes E, Johansen H, Keil TMI, Knudtsen IS, Langørgen S, Selnæs KM, Bathen TF, Elschot M. Abrahamsen BS, et al. Among authors: aksnessaether by. J Magn Reson Imaging. 2024 Apr 28. doi: 10.1002/jmri.29386. Online ahead of print. J Magn Reson Imaging. 2024. PMID: 38679841